New Delhi: India’s fight against Covid 19 virus to get stronger. An expert panel has given its nod to use Covaxin for the children aged between 2-18 years. Final approval will be given by the Drug Controller General of India ( DGCI).
When that approval does come, Covaxin will be the second vaccine cleared for use on kids; in August Zydus Cadila’s three-dose DNA jab was allowed to be used on adults and children over 12.
Last week manufacturers Bharat Biotech said it had submitted data on vaccine trials on children.
The Covaxin vaccine tested on children is the same formulation as used on adults, but separate trials were needed to guarantee safety and efficacy on younger recipients.
Data on these trials has not been made public yet, but tests were conducted on 1,000+ children across the country. The panel, however, noted the trial on kids showed similar efficacy rates as that on adults.
Discussion about this post